Overview
Top Medical Research Studies
We observed that the long-term use of this treatment system significantly reduced the risk of pneumonia recurrence. It also appeared to help prevent the emergence of certain cancers in older patients suffering from interstitial pneumonia. Surprisingly, we found a link between interstitial pneumonia and an increased risk of depression, likely driven by prolonged glucocorticoid use.
While some patients showed promise under this treatment, those battling both interstitial pneumonia and depression responded less favorably. We suggested that increasing the amount of dehydroepiandrosterone in the treatment could be beneficial. Throughout our experience, we noted that the characteristics of chronic fatigue syndrome align closely with those of interstitial pneumonia, arguing against the notion that they should be viewed as separate conditions.
Overall, our approach not only alleviated inflammation but did not suppress the fibrotic processes in the long run. We made modifications to the treatment to lower the risks of vascular complications. The main strength of our treatment lies in creating a hormonal environment that helps tackle immune deficiencies using vitamin C, which faces lower resistance in the body compared to steroid treatments.
Our analysis revealed that a significant portion of patients experienced symptoms aligning with CFS, characterized by a prolonged illness that required extensive medical care. Patients tended to respond better to a combination of both the old and new vitamin C infusions rather than relying solely on the traditional treatment.
Notably, the combined treatment was more effective, suggesting that there may be underlying issues related to hormone levels in CFS patients that are influenced by vitamin C therapy. However, we also noted potential side effects with the sole use of the new vitamin C infusion. A careful balance between the different infusion approaches is crucial for achieving the best outcomes in CFS management.
Overall, while we observed some promising responses to vitamin C treatments, more research is necessary to fully understand its effectiveness and to optimize treatment strategies for those suffering from chronic fatigue syndrome.
What we found is quite promising. High doses of vitamin C appeared to reduce the duration of disease symptoms and helped decrease antibody levels associated with EBV. Notably, we observed that patients with higher levels of vitamin C in their plasma generally had lower levels of certain EBV antibodies, suggesting a potential link that might help manage symptoms of CFS.
Furthermore, there was an interesting connection between vitamin D levels and EBV antibodies as well. Patients who had high levels of vitamin D showed lower levels of EBV early antigen antibodies. This points towards a holistic approach to managing CFS, where both vitamin C and vitamin D may play beneficial roles. Overall, our findings hint at an encouraging effect of high dose vitamin C therapy in helping those grappling with CFS due to EBV.
Most Useful Reviews
Medical Researches
- All Researches
What we found is quite promising. High doses of vitamin C appeared to reduce the duration of disease symptoms and helped decrease antibody levels associated with EBV. Notably, we observed that patients with higher levels of vitamin C in their plasma generally had lower levels of certain EBV antibodies, suggesting a potential link that might help manage symptoms of CFS.
Furthermore, there was an interesting connection between vitamin D levels and EBV antibodies as well. Patients who had high levels of vitamin D showed lower levels of EBV early antigen antibodies. This points towards a holistic approach to managing CFS, where both vitamin C and vitamin D may play beneficial roles. Overall, our findings hint at an encouraging effect of high dose vitamin C therapy in helping those grappling with CFS due to EBV.
Initially, the old infusion method, alongside some antibiotics, showed effectiveness in managing the patient’s pneumonia, which was a part of the CFS symptoms. However, over time, pneumonia symptoms returned, prompting us to alternate between the old and new vitamin C treatments along with longer antibiotic use. Remarkably, this switch led to a notable reduction in pneumonia signs.
We found that the new vitamin C infusion treatment dramatically increased urine excretion of certain hormones, suggesting an enhancement of the body’s steroid activities. Notably, some evidence indicated that the dehydroepiandrosterone was converted into testosterone, which could positively influence the CFS control. However, our searches for changes in immune response didn’t yield significant results.
Ultimately, our observations suggest that the new vitamin C treatment could help manage CFS by boosting cortisol and testosterone levels, but additional studies would be necessary to fully understand its effectiveness in isolation.
We observed that the long-term use of this treatment system significantly reduced the risk of pneumonia recurrence. It also appeared to help prevent the emergence of certain cancers in older patients suffering from interstitial pneumonia. Surprisingly, we found a link between interstitial pneumonia and an increased risk of depression, likely driven by prolonged glucocorticoid use.
While some patients showed promise under this treatment, those battling both interstitial pneumonia and depression responded less favorably. We suggested that increasing the amount of dehydroepiandrosterone in the treatment could be beneficial. Throughout our experience, we noted that the characteristics of chronic fatigue syndrome align closely with those of interstitial pneumonia, arguing against the notion that they should be viewed as separate conditions.
Overall, our approach not only alleviated inflammation but did not suppress the fibrotic processes in the long run. We made modifications to the treatment to lower the risks of vascular complications. The main strength of our treatment lies in creating a hormonal environment that helps tackle immune deficiencies using vitamin C, which faces lower resistance in the body compared to steroid treatments.
Our analysis revealed that a significant portion of patients experienced symptoms aligning with CFS, characterized by a prolonged illness that required extensive medical care. Patients tended to respond better to a combination of both the old and new vitamin C infusions rather than relying solely on the traditional treatment.
Notably, the combined treatment was more effective, suggesting that there may be underlying issues related to hormone levels in CFS patients that are influenced by vitamin C therapy. However, we also noted potential side effects with the sole use of the new vitamin C infusion. A careful balance between the different infusion approaches is crucial for achieving the best outcomes in CFS management.
Overall, while we observed some promising responses to vitamin C treatments, more research is necessary to fully understand its effectiveness and to optimize treatment strategies for those suffering from chronic fatigue syndrome.
However, our findings highlight four key issues. First, it is still debated whether these treatments should continue on a maintenance basis when no acute symptoms are present. Some evidence suggests their ongoing use is crucial for halting an evolving bacterial colony in patients with immune deficiencies.
Second, we noted an emerging problem with drug-resistant bacteria, which posed challenges in treatment effectiveness. New antibiotics, like kanamycin, showed promise in addressing this resistance and improving pneumonia symptoms.
Third, we observed a decline in bone marrow function in one patient over a nine-year observation period, indicating potential fibrosis similar to that seen in lung tissue.
Lastly, we encountered a case where a female patient developed breast cancer during treatment, raising concerns about the risks of prolonged autoimmune conditions in older adults. Interestingly, dehydroepiandrosterone appeared to support hepatic recovery during cancer chemotherapy, suggesting complex interactions between treatments and patient responses.
Overall, while vitamin C plays a role in the treatment approach, the complexities of chronic fatigue syndrome and interstitial pneumonia present challenges that require further investigation.
User Reviews
- All Reviews
- Positive Reviews
- Negative Reviews
Frequently Asked Questions
Chronic Fatigue Syndrome (CFS), also known as Myalgic Encephalomyelitis (ME), is a complex and debilitating condition characterized by profound fatigue that doesn’t improve with rest and worsens with physical or mental activity. This crippling fatigue is often accompanied by a variety of symptoms, including sleep disturbances, cognitive difficulties, muscle pain, and joint pain. Unlike typical tiredness, the fatigue experienced in CFS is long-lasting, and it can significantly hinder everyday activities and overall quality of life.
The precise cause of CFS remains unknown, but it is believed to be influenced by a combination of genetic, environmental, immunological, and psychological factors. Diagnosis primarily relies on a careful assessment of symptoms, as there are no definitive laboratory tests available. Treatment options focus on symptom management and may include lifestyle changes, physical therapy, medication for pain management, and cognitive behavioral therapy. Given the complexity and variability of the condition, individuals with CFS should consult healthcare professionals who specialize in this area to develop personalized management strategies.
Vitamin C, also known as ascorbic acid, is a water-soluble vitamin that plays a critical role in numerous bodily functions. As an essential nutrient, it contributes to the growth and repair of tissues in the body, and it is vital for the production of collagen, an important protein that helps maintain skin, cartilage, tendons, ligaments, and blood vessels. Additionally, Vitamin C acts as a powerful antioxidant, which means it helps combat free radicals—unstable molecules that can cause oxidative stress and contribute to various chronic diseases.
Moreover, Vitamin C enhances iron absorption from plant-based foods, making it a vital component for those following vegetarian or vegan diets. While many people get sufficient Vitamin C from a well-balanced diet that includes fruits and vegetables like oranges, strawberries, kiwi, broccoli, and bell peppers, some individuals might require supplementation. It's generally recommended to stay within the daily intake guidelines, as excessive consumption can lead to gastrointestinal disturbances. Overall, Vitamin C is not just a skincare celebrity—it's a fundamental part of maintaining overall health and well-being.
Chronic Fatigue Syndrome (CFS) is a complex condition characterized by extreme fatigue that doesn't improve with rest and can worsen with physical or mental exertion. While vitamin C is well-known for its role in supporting the immune system and combating oxidative stress, there's limited research specifically addressing its efficacy in treating CFS. Some studies suggest that vitamin C may help alleviate certain symptoms of fatigue due to its antioxidant properties, which could help reduce inflammation and promote overall wellbeing. However, it is essential to note that vitamin C should not be seen as a cure for CFS.
If you are considering vitamin C supplementation as part of your management strategy for CFS, it’s crucial to consult with a healthcare professional. They can provide personalized advice based on your individual health needs and circumstances. Additionally, it's beneficial to adopt a holistic approach that may include proper nutrition, adequate rest, and perhaps other therapies geared towards managing CFS symptoms. Ultimately, while vitamin C may offer some benefits, it's not a definitive solution for everyone suffering from Chronic Fatigue Syndrome.
Based on user reviews, the time it typically takes to see results from this vitamin C supplement for Chronic Fatigue Syndrome can vary. Some users have reported noticeable improvements within a few weeks, mentioning immediate boosts in energy levels and reductions in fatigue after just a few days of use (Read Review). Others found significant benefits after a longer duration, often recommending continued use for at least a month or more to fully realize the positive effects, especially during recovery from illness or when combined with other vitamins (Read Review).
For those regularly incorporating the supplement into their routine, users have highlighted sustained improvements over months, with some stating that it effectively resolved their symptoms after a year of consistent use (Read Review). Overall, while many experience different timelines, the consensus is that patience and continued use will likely lead to better management of Chronic Fatigue Syndrome symptoms.
Scientific research suggests that high-dose vitamin C may offer potential benefits for those suffering from Chronic Fatigue Syndrome (CFS), particularly when linked to Epstein-Barr virus (EBV) infections. A study involving 178 patients found that vitamin C therapy not only reduced the duration of symptoms but also correlated with lower levels of EBV antibodies, indicating a potential role in managing CFS symptoms ([1]). Additionally, other research exploring vitamin C in combination with treatments such as dehydroepiandrosterone (DHEA) and hormonal therapy has shown some promise in improving outcomes for patients. It was observed that a mix of different vitamin C infusion methods yielded better patient responses, suggesting that hormone levels may influence how well patients with CFS manage their symptoms ([4]).
However, the findings also highlight that managing CFS involves complexities that are not fully understood. While some studies report positive outcomes associated with vitamin C therapy, others emphasize the need for further research to ascertain its effectiveness and safety over a longer term. As vitamin C treatments continue to show mixed results, it remains crucial for patients to discuss these options with their healthcare providers and consider them as part of a broader treatment strategy for CFS ([2]).
Based on user reviews, many individuals have reported significant improvements in their chronic fatigue syndrome symptoms after using this vitamin C supplement. Some users have noticed immediate benefits, such as reduced physical fatigue within a few days of daily consumption, with one user highlighting that it has helped make this supplement a top choice for managing their fatigue (Read Review). Additionally, long-term use has proven effective for others; one reviewer stated that after a year of consistent use, they experienced complete resolution of their chronic fatigue syndrome symptoms and even noticed positive changes in their legs (Read Review).
Moreover, users have shared that the supplement has contributed to general wellness, including enhancements in immune health and significant reductions in fatigue during recovery periods, especially when complemented with other vitamins (Read Review). While some have specifically mentioned the alleviation of particular symptoms, such as nosebleeds and improved energy levels, it's essential to note that individual results can vary widely depending on personal health circumstances and adherence to a consistent routine (Read Review). Overall, the positive anecdotal experiences indicate a hopeful outlook for those seeking relief from chronic fatigue syndrome.
Based on user reviews, many individuals have found combining this vitamin C supplement with other supplements effective for managing Chronic Fatigue Syndrome. One reviewer recounted their experience of using the supplement alongside zinc and vitamin D3 during recovery from COVID-19, noting significant improvements in both immune function and their fatigue levels (Read Review). Another user confirmed feeling much better after adding vitamin D3 to their routine, suggesting a beneficial synergy between these supplements and vitamin C (Read Review).
Furthermore, consistent use of vitamin C in combination with other vitamins may enhance overall health benefits, as users reported increased energy and reduced fatigue, enabling better management of their symptoms (Read Review). While experiences can vary, the general consensus points to positive outcomes when this vitamin C is integrated with additional supportive supplements, suggesting a comprehensive approach to tackling the challenges of Chronic Fatigue Syndrome.
Based on user reviews, the optimal dose of Vitamin C for treating Chronic Fatigue Syndrome appears to vary among individuals. Some users have reported taking vitamin C in conjunction with other supplements—like vitamin D3 and zinc—to enhance its efficacy. For instance, one reviewer noted that alongside 2g of vitamin D3, they felt significantly better with their chronic fatigue symptoms (Read Review). Another user reported that taking vitamin C nightly eliminated symptoms that had been troublesome, indicating that consistent dosing can yield positive results (Read Review).
Moreover, some users suggested timing the dose for optimal benefits, as one individual reported reduced morning fatigue when taking their vitamin C before bed (Read Review). It is important to note, however, that individuals may respond differently to various forms and combinations of vitamin C, so personal experimentation might be necessary to find the right dosage and timing that alleviates symptoms of Chronic Fatigue Syndrome effectively.
What we found is quite promising. High doses of vitamin C appeared to reduce the duration of disease symptoms and helped decrease antibody levels associated with EBV. Notably, we observed that patients with higher levels of vitamin C in their plasma generally had lower levels of certain EBV antibodies, suggesting a potential link that might help manage symptoms of CFS.
Furthermore, there was an interesting connection between vitamin D levels and EBV antibodies as well. Patients who had high levels of vitamin D showed lower levels of EBV early antigen antibodies. This points towards a holistic approach to managing CFS, where both vitamin C and vitamin D may play beneficial roles. Overall, our findings hint at an encouraging effect of high dose vitamin C therapy in helping those grappling with CFS due to EBV.
Our analysis revealed that a significant portion of patients experienced symptoms aligning with CFS, characterized by a prolonged illness that required extensive medical care. Patients tended to respond better to a combination of both the old and new vitamin C infusions rather than relying solely on the traditional treatment.
Notably, the combined treatment was more effective, suggesting that there may be underlying issues related to hormone levels in CFS patients that are influenced by vitamin C therapy. However, we also noted potential side effects with the sole use of the new vitamin C infusion. A careful balance between the different infusion approaches is crucial for achieving the best outcomes in CFS management.
Overall, while we observed some promising responses to vitamin C treatments, more research is necessary to fully understand its effectiveness and to optimize treatment strategies for those suffering from chronic fatigue syndrome.
However, our findings highlight four key issues. First, it is still debated whether these treatments should continue on a maintenance basis when no acute symptoms are present. Some evidence suggests their ongoing use is crucial for halting an evolving bacterial colony in patients with immune deficiencies.
Second, we noted an emerging problem with drug-resistant bacteria, which posed challenges in treatment effectiveness. New antibiotics, like kanamycin, showed promise in addressing this resistance and improving pneumonia symptoms.
Third, we observed a decline in bone marrow function in one patient over a nine-year observation period, indicating potential fibrosis similar to that seen in lung tissue.
Lastly, we encountered a case where a female patient developed breast cancer during treatment, raising concerns about the risks of prolonged autoimmune conditions in older adults. Interestingly, dehydroepiandrosterone appeared to support hepatic recovery during cancer chemotherapy, suggesting complex interactions between treatments and patient responses.
Overall, while vitamin C plays a role in the treatment approach, the complexities of chronic fatigue syndrome and interstitial pneumonia present challenges that require further investigation.
References
- Mikirova N, Hunninghake R. Effect of high dose vitamin C on Epstein-Barr viral infection. Med Sci Monit. 2014;20:725. doi:10.12659/MSM.890423
- Kodama M, Kodama T. Four problems with the clinical control of interstitial pneumonia, or chronic fatigue syndrome, using the megadose vitamin C infusion system with dehydroepiandrosterone-cortisol annex. In Vivo. 2006;20:285.
- Kodama M, Kodama T. The clinical course of interstitial pneumonia alias chronic fatigue syndrome under the control of megadose vitamin C infusion system with dehydroepiandrosterone-cortisol annex. Int J Mol Med. 2005;15:109.
- Kodama M, Kodama T, Murakami M. The value of the dehydroepiandrosterone-annexed vitamin C infusion treatment in the clinical control of chronic fatigue syndrome (CFS). II. Characterization of CFS patients with special reference to their response to a new vitamin C infusion treatment. In Vivo. 1996;10:585.
- Kodama M, Kodama T, Murakami M. The value of the dehydroepiandrosterone-annexed vitamin C infusion treatment in the clinical control of chronic fatigue syndrome (CFS). I. A Pilot study of the new vitamin C infusion treatment with a volunteer CFS patient. In Vivo. 1996;10:575.
